MedPath

Cipherome, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:6

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Completed
Conditions
Acute Lymphoblastic Leukemia, Pediatric
Adverse Drug Event
First Posted Date
2021-02-25
Last Posted Date
2023-02-16
Lead Sponsor
Cipherome, Inc.
Target Recruit Count
80
Registration Number
NCT04770922
Locations
🇺🇸

Stanford University, Stanford, California, United States

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

Not Applicable
Completed
Conditions
Bleeding
Ischemic Stroke
Myocardial Infarction
Thrombosis
Stent Thrombosis
First Posted Date
2021-01-08
Last Posted Date
2023-09-29
Lead Sponsor
Cipherome, Inc.
Target Recruit Count
300
Registration Number
NCT04702113
Locations
🇺🇸

Doctors Hospital at Renaissance, Edinburg, Texas, United States

Association Between Genetic Variant Scores and DOACs (DARES2)

Completed
Conditions
Drug-Related Side Effects and Adverse Reactions
Iatrogenic Disorder
First Posted Date
2020-10-22
Last Posted Date
2023-08-16
Lead Sponsor
Cipherome, Inc.
Target Recruit Count
200
Registration Number
NCT04597593
Locations
🇰🇷

SNUBH, Seongnam-si, Gyonggi-do, Korea, Republic of

DOAC ADRs Retrospective Study on Genetic Variations

Completed
Conditions
Drug-Related Side Effects and Adverse Reactions
Treatment Failure
First Posted Date
2020-10-08
Last Posted Date
2023-02-16
Lead Sponsor
Cipherome, Inc.
Target Recruit Count
210
Registration Number
NCT04580589
Locations
🇺🇸

Santa Clara Valley Medical Center, Santa Clara, California, United States

Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects

Completed
Conditions
Ischemic Stroke
Myocardial Infarction
Stent Thrombosis
Acute Coronary Syndrome
First Posted Date
2020-10-08
Last Posted Date
2023-02-16
Lead Sponsor
Cipherome, Inc.
Target Recruit Count
200
Registration Number
NCT04580602
Locations
🇰🇷

SNUBH, Seongnam-si, Gyonggi-do, Korea, Republic of

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath